Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jennifer L. Good currently holds 34,751 shares of PENWEST PHARMACEUTICALS CO (PPCO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer L. Good has been a net seller of PPCO stock. They have purchased $128.6K and sold $4.5M worth of shares.
Jennifer L. Good's most recent insider trade was on Sep 17, 2024, when they sold 15,000 shares at $0.00 per share.
Jennifer L. Good serves as Executive at PENWEST PHARMACEUTICALS CO (PPCO). They have executed 58 insider transactions totaling $4.7M over their tenure at the company.
Jennifer L. Good holds the position of Executive at PENWEST PHARMACEUTICALS CO, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Jennifer L. Good has shown a selling trading pattern, with $128.6K in total purchases and $4.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jennifer L. Good was on Sep 9, 2024, when they sold $1.9M worth of RYTM shares. This transaction involved 37,241 shares at $50.45 per share.
Jennifer L. Good currently owns 34,751 shares of PENWEST PHARMACEUTICALS CO (PPCO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jennifer L. Good's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jennifer L. Good has 58 Form 4 filings on record as an insider at PENWEST PHARMACEUTICALS CO.
Set alerts for Jennifer L. Good and 40,000+ other insiders.